Concepedia

S Shu

SS

Statistics

Publications

27

Citations

3.2K

H-Index

23

Active since

1977

Affiliations

National Cancer Institute(Current)

University of Michigan

National Institutes of Health

Cleveland Clinic

Cleveland Foundation

S Shu is an author at National Cancer Institute specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1977–2004

27

Publications

27

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.

Gary J. Nabel, E G Nabel, Zhiyong Yang et al. · Proceedings of the National Academy of Sciences · 1993 · 886 citations · Full text

, , +20

The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.

James J. Mulé, S Shu, S A Rosenberg · The Journal of Immunology · 1985 · 294 citations · Full text

, , +23

Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2

Hirohisa Yoshizawa, Alfred E. Chang, S Shu · The Journal of Immunology · 1991 · 213 citations

Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.

James J. Mulé, Jin‐Hao Yang, R L Afreniere et al. · The Journal of Immunology · 1987 · 212 citations

, , +21

Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.

Alfred E. Chang, Atsushi Aruga, Mark J. Cameron et al. · Journal of Clinical Oncology · 1997 · 166 citations

1–5 of 27